查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1733213

全球空胶囊市场规模（按最终用户产业、产品、治疗应用、区域范围和预测）

Global Empty Capsules Market Size By End-User Industry, By Product, By Therapeutic Application, By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 | 商品交期: 2-3个工作天内

价格
简介目录

空胶囊的市场规模及预测

2024 年空胶囊市场规模价值为 30.7 亿美元，预计到 2032 年将达到 50.2 亿美元，2026 年至 2032 年的复合年增长率为 7.00%。

空胶囊是药品、化学品和粉末物质的重要载体，广泛应用于製药、营养保健品、化妆品和实验室等各行业。

这些胶囊为固态剂型，主要用于口服和容纳活性药物成分 (API)、草药粉和维生素补充剂。

由于感染疾病和病毒性疾病的盛行率不断上升，以及空胶囊应用范围的扩大，空胶囊的需求预计也会成长。

此外，旨在提高製药能力和增加公共和政府对医疗保健的投资的研发力度不断加大，可能在未来几年进一步推动空胶囊市场的扩张。

全球空胶囊市场动态

影响全球空胶囊市场的关键市场动态是：

关键市场驱动因素

转向便捷的剂型：根据国际药用辅料理事会 2022 年的一项调查，68% 的消费者选择胶囊而不是其他口服剂型，因为它们易于吞嚥和携带。

无明胶胶囊的需求不断增加：美国FDA 报告称，2020 年至 2022 年间，使用素食胶囊的新药核准将增加 25%。

製药业成长：根据世界卫生组织的报告，2021年全球医药品研究开发费用将比2020年增加5.5%，这将进一步增加对用于包装新药物製剂的空胶囊的需求。

主要问题

原料供应挑战：联合国粮食及农业组织（FAO）报告称，由于COVID-19疫情导致牲畜供应和肉类营运中断，2019年至2021年全球明胶产量将下降7.5％。

监管复杂性：2021 年，美国FDA 实施了新的指导方针，要求提高药品中使用的明胶来源的可追溯性和检验，从而增加了胶囊製造商的合规成本。欧洲药品管理局报告称，2020年至2022年期间，有关空胶囊成分和安全性的监管问询数量增加了12%，减缓了新药申请的核准流程。

来自替代品的竞争：根据国际药用辅料理事会 2022 年的一项消费者调查，28% 的受访者更喜欢口溶锭而不是胶囊，理由是其起效更快是主要因素。

主要趋势

素食/素食胶囊需求增加：国际药用辅料理事会 2021 年的一项调查发现，65% 的全球消费者积极寻求素食和纯素食补充剂和药品胶囊。

特种胶囊的成长：随着製药公司不断创新以提高生物有效性和患者体验，美国FDA 预计，利用特种胶囊技术的新药申请将在 2020 年至 2022 年间增长 19%。

对明胶替代品的需求不断增加：越来越多的饮食、文化和宗教因素推动了人们对无明胶胶囊的偏好。这一趋势反映了多样化的消费者偏好和市场需求，推动了对替代胶囊材料（如 HPMC 和普鲁兰胶胶囊等素食选择）的需求。

目录

第一章 全球空胶囊市场介绍

  • 市场概览
  • 研究范围
  • 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

  • 资料探勘
  • 验证
  • 第一手资料
  • 资料来源列表

第四章 全球空胶囊市场展望

  • 概述
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 波特五力模型
  • 价值链分析
  • 法律规范

第五章全球空胶囊市场（依最终用户产业）

  • 概述
  • 製药业
  • 营养保健品产业
  • 化妆品产业
  • 临床研究所

第六章全球空胶囊市场（依产品）

  • 概述
  • 明胶
  • 非明胶

第七章全球空胶囊市场（依治疗应用）

  • 概述
  • 抗生素和抗菌药物
  • 维生素和营养补充剂
  • 制酸剂和肠道调节剂
  • 抗发炎药物
  • 抗血液製品

第八章全球空胶囊市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 其他的
    • 拉丁美洲
    • 中东和非洲

第九章全球空胶囊市场竞争格局

  • 概述
  • 企业市场排名
  • 供应商格局
  • 重点发展策略

第十章 公司简介

  • Capsugel（现为 Lonza）
  • ACG Worldwide
  • Qualicaps
  • Suheung Co. Ltd.
  • CapsCanada Corporation
  • Sunil Healthcare Limited
  • Shanxi Guangsheng Medicinal Capsules Co. Ltd
  • Bright Pharma Caps, Inc.
  • Snail Pharma Industry Co. Ltd.
  • Natural Capsules Limited

第十一章 重大进展

  • 产品发布/开发
  • 合併与收购
  • 业务扩展
  • 伙伴关係与合作

第十二章 附录

  • 相关调查
简介目录
Product Code: 33385

Empty Capsules Market Size And Forecast

Empty Capsules Market size was valued at USD 3.07 Billion in 2024 and is projected to reach USD 5.02 Billion by 2032, growing at a CAGR of 7.00% from 2026 to 2032.

Empty capsules serve as essential carriers for pharmaceutical drugs, chemicals, and powdered substances, widely utilized in various industries including pharmaceuticals, nutraceuticals, cosmetics, and research laboratories.

Acting as solid dosage forms, these capsules are primarily used for oral administration, housing active pharmaceutical ingredients (APIs), herbal powders, and vitamin supplements.

The demand for empty capsules is expected to grow due to the rising prevalence of infectious and viral diseases, along with their increasing application across multiple sectors.

Additionally, heightened research and development efforts aimed at advancing pharmaceutical capabilities, coupled with growing public and government investments in healthcare, are set to further drive market expansion for empty capsules in the coming years.

Global Empty Capsules Market Dynamics

The key market dynamics that are shaping the global empty capsules market include:

Key Market Drivers:

Shift Towards Convenient Dosage Forms: A 2022 survey by the International Pharmaceutical Excipients Council found that 68% of consumers chose capsules over other oral dosage forms due to their ease of swallowing and portability.

Increasing Demand for Gelatin-Free Capsules: The U.S. FDA reported a 25% increase in approvals for new drug applications using vegetarian capsules from 2020 to 2022, driven by growing consumer demand for plant-based and vegan-friendly options.

Pharmaceutical Industry Growth: The WHO reported that global pharmaceutical R&D spending increased by 5.5% in 2021 compared to 2020, further fueling the need for empty capsules to package new drug formulations.

Key Challenges:

Raw Material Supply Challenges: The Food and Agriculture Organization (FAO) reported a 7.5% decrease in global gelatin production from 2019 to 2021, as the COVID-19 pandemic disrupted livestock supplies and slaughterhouse operations.

Regulatory Complexity: The U.S. FDA implemented new guidelines in 2021 requiring enhanced traceability and verification for gelatin sources used in pharmaceutical products, leading to increased compliance costs for capsule producers. The European Medicines Agency reported a 12% increase in the number of regulatory queries related to empty capsule composition and safety from 2020 to 2022, slowing the approval process for new drug applications.

Competition from Alternative Delivery Forms: A 2022 consumer survey by the International Pharmaceutical Excipients Council found that 28% of respondents preferred orally disintegrating tablets over capsules, citing faster onset of action as a key driver.

Key Trends:

Rising Demand for Vegetarian & Plant-Based Capsules: A 2021 survey by the International Pharmaceutical Excipients Council found that 65% of consumers globally actively seek out vegetarian or vegan-friendly capsule options for supplements and medications.

Growth of Specialty Capsule Formats: The U.S. FDA saw a 19% increase in new drug applications utilizing specialized capsule technologies from 2020 to 2022, as pharmaceutical companies innovate to improve bioavailability and patient experience.

Increasing Demand for Gelatin Alternatives: Growing dietary, cultural, and religious considerations are leading to a rising preference for gelatin-free capsules. This trend reflects diverse consumer preferences and market needs, boosting demand for alternative capsule materials like vegetarian options, including HPMC and pullulan capsules.

Global Empty Capsules Market Regional Analysis

Here is a more detailed regional analysis of the global empty capsules market:

North America

North America substantially dominates the global empty capsules market driven by the large pharmaceutical industry and R&D investments.

According to the IQVIA Institute, the North American pharmaceutical market was valued at USD 612 Billion in 2020, accounting for nearly half of the global market.

The U.S. National Institutes of Health reported a 7.5% year-over-year increase in pharmaceutical R&D spending in the North American region from 2020 to 2021, reaching over USD 300 Billion.

A 2022 survey by the International Pharmaceutical Excipients Council revealed that 72% of North American consumers prefer purchasing medications in specialty capsule formats like gastro-resistant or controlled-release.

The U.S. Council for Responsible Nutrition reported that the North American nutraceuticals market reached USD 60 Billion in 2021, a 7.5% increase from 2020 levels.

Health Canada data shows that the value of natural health product licenses, which often utilize empty capsules, grew by 9% in the country from 2020 to 2022.

Asia Pacific

Asia Pacific is anticipated to witness the fastest growth in the empty capsules market during the forecast period owing to the expanding pharmaceutical and nutraceuticals industry.

According to the India Brand Equity Foundation, the Indian pharmaceutical industry grew by 18.8% in 2021 to reach $42 billion, driving greater demand for empty capsules.

A 2022 report by the Japan Health and Nutrition Food Association found that the Japanese nutraceuticals market reached $30 billion, up 12% from 2020 levels.

The China Vegetarian Association reported a 20% increase in the sales of plant-based supplements packaged in vegetarian capsules from 2020 to 2022.

A 2021 survey by the International Pharmaceutical Excipients Council found that 68% of consumers in the Asia Pacific region actively seek out clean-label and non-animal-derived capsule products.

The OECD reported that China's per capita healthcare expenditure grew by 9.2% annually from 2020 to 2022, improving access to medicines packaged in empty capsules.

The Indian government's 2022 budget allocated $10 billion towards expanding the country's universal healthcare coverage, which is expected to drive greater pharmaceutical consumption.

Global Empty Capsules Market: Segmentation Analysis

The Global Empty Capsules Market is segmented based on End-User Industry, Product, Therapeutic Application, And Geography.

Empty Capsules Market, By End-User Industry

  • Pharmaceutical Industry
  • Nutraceutical Industry
  • Cosmetics Business
  • Clinical Research Organization

Based on the End-User Industry, the Global Empty Capsules Market is bifurcated into the Pharmaceutical Industry, Nutraceutical Industry, Cosmetics Business, and Clinical Research Organization. The Pharmaceutical segment is experiencing growth in the Global Empty Capsules Market owing to the increasing production and usage of a wide range of drugs by healthcare practitioners. Empty capsules are extensively utilized in the pharmaceutical industry for the treatment of infectious and chronic diseases, as they help extend the shelf life of active ingredients in medications.

Empty Capsules Market, By Product

  • Gelatin
  • Non-Gelatin

Based on the Product, the Global Empty Capsules Market is bifurcated into Gelatin and Non-Gelatin. The Gelatin segment dominates in the Global Empty Capsules Market. The gelatin-based empty capsules are made from various sources, including pig meat gelatin, bovine-derived gelatin, and bone meal gelatin. These capsules are composed of pure protein, are tasteless, and are both gluten-free and GMO-free. Furthermore, they are customized in terms of color, shape, and size to meet specific needs and accommodate diverse demographics.

Empty Capsules Market, By Therapeutic Application

  • Antibiotic and Antibacterial Drugs
  • Vitamins and Dietary Supplements
  • Antacid and Antiflatulent Preparations
  • Anti-inflammatory Drugs
  • Antianemic Preparations

Based on the Therapeutic Application, the Global Empty Capsules Market is bifurcated into Antibiotic and Antibacterial Drugs, Vitamins and Dietary Supplements, Antacid and Antiflatulent Preparations, Anit-inflammatory Drugs, and Antianemic Preparations. The Antibiotic and Antibacterial Drugs segment dominates in the Global Empty Capsules Market owing to high demand for commonly used drugs such as penicillin, tetracycline, sulfonamide, and nitrofurantoin. Rising cases of bacterial infections, including tuberculosis, and bladder, and gastrointestinal infections, continue to drive demand for these medications. Additionally, ongoing research and development in antibiotic and antibacterial drugs further support market growth.

Key Players

The "Global Empty Capsules Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Capsugel (now Lonza), ACG Worldwide, Qualicaps, Suheung Co., Ltd., CapsCanada Corporation, Sunil Healthcare Limited, Shanxi Guangsheng Medicinal Capsules Co., Ltd., Bright Pharma Caps, Inc., Snail Pharma Industry Co., Ltd., Natural Capsules Limited.

  • This section offers in-depth analysis through a company overview, position analysis, the regional and industrial footprint of the company, and the ACE matrix for insightful competitive analysis. The section also provides an exhaustive analysis of the financial performances of mentioned players in the given market.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Empty Capsules Market Key Developments

  • In March 2023, VANTAGE NUTRITION, an ACG company, announced the acquisition of ComboCap, Inc. in the United States and BioCap in South Africa, with plans to grow their technology and footprint in North America and around the world.
  • In January 2022, Xi'an Le-Nutra Ingredients Inc. exported 8.0 million HPMC capsules to Latvia, Europe. These capsules did not contain titanium dioxide (TiO2), reflecting the company's efforts to accommodate regional demand for the product.
  • In July 2020, QUALICAPS Group, which was previously part of Mitsubishi Chemical Holdings Corporation (MCHC), was transferred to Mitsubishi Chemical Corporation (MCC). This transition enables QUALICAPS to make use of its network and increase its capsule business.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL EMPTY CAPSULES MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL EMPTY CAPSULES MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis
  • 4.5 Regulatory Framework

5 GLOBAL EMPTY CAPSULES MARKET, BY END-USER INDUSTRY

  • 5.1 Overview
  • 5.2 Pharmaceutical Industry
  • 5.3 Nutraceutical Industry
  • 5.4 Cosmetics Business
  • 5.5 Clinical Research Organization

6 GLOBAL EMPTY CAPSULES MARKET, BY PRODUCT

  • 6.1 Overview
  • 6.2 Gelatin
  • 6.3 Non-Gelatin

7 GLOBAL EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION

  • 7.1 Overview
  • 7.2 Antibiotic and Antibacterial Drugs
  • 7.3 Vitamins and Dietary Supplements
  • 7.4 Antacid and Antiflatulent Preparations
  • 7.5 Anti-inflammatory Drugs
  • 7.6 Antianemic Preparations

8 GLOBAL EMPTY CAPSULES MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Rest of the World
    • 8.5.1 Latin America
    • 8.5.2 Middle East and Africa

9 GLOBAL EMPTY CAPSULES MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market ranking
  • 9.3 Vendor Landscape
  • 9.4 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 Capsugel (now Lonza)
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 ACG Worldwide
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 Qualicaps
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 Suheung Co. Ltd.
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 CapsCanada Corporation
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 Sunil Healthcare Limited
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Developments
  • 10.7 Shanxi Guangsheng Medicinal Capsules Co. Ltd
    • 10.7.1 Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Outlook
    • 10.7.4 Key Developments
  • 10.8 Bright Pharma Caps, Inc.
    • 10.8.1 Overview
    • 10.8.2 Financial Performance
    • 10.8.3 Product Outlook
    • 10.8.4 Key Developments
  • 10.9 Snail Pharma Industry Co. Ltd.
    • 10.9.1 Overview
    • 10.9.2 Financial Performance
    • 10.9.3 Product Outlook
    • 10.9.4 Key Developments
  • 10.10 Natural Capsules Limited
    • 10.10.1 Overview
    • 10.10.2 Financial Performance
    • 10.10.3 Product Outlook
    • 10.10.4 Key Developments

11 KEY DEVELOPMENTS

  • 11.1 Product Launches/Developments
  • 11.2 Mergers and Acquisitions
  • 11.3 Business Expansions
  • 11.4 Partnerships and Collaborations

12 APPENDIX

  • 12.1 Related Research